Kenyan marathon runner Ekiru receives 10-year doping ban | Multisport.ph

OCTOBER 27, 2022

One of the positive tests of Titus Ekiru came at the 2021 Milan Marathon

Photo by Ezra Shaw/Getty Images North America/Getty Images via AFP

(Reuters) – Kenyan marathon runner Titus Ekiru has been banned for 10 years, the Athletics Integrity Unit (AIU) said Monday, for both doping and tampering in a case that involved collusion with a high-ranking doctor in a Kenyan hospital.

One of his positive tests, for triamcinolone acetonide, came at the Milan Marathon in May 2021, which he won in a time of 2:02:57. which would currently rank him the seventh-fastest all-time marathon athlete.

The ban comes after an investigation found the 31-year-old obstructed the AIU’s probe into two adverse analytical findings (AAFs) by using false information and documentation.

His ban runs from the date of his provisional suspension on June 28, 2022 until June 27, 2032. His results on and since May 16th, 2021 have been erased and he must forfeit all race prizes and money.

The ban comes after an investigation found the 31-year-old obstructed the AIU’s probe into two adverse analytical findings by using false information and documentation

Ekiru also tested positive after winning the Abu Dhabi Marathon on Nov. 26 for pethidine and its marker norpethidine.

An investigation showed Ekiru received injections of banned substances during undocumented hospital visits, and the AIU was able to determine medical documents submitted to explain his AAFs were forged and inconsistent with hospital and pharmacy records.

“For athletes involved in doping and the entourage who assist them, there is one strong message from this case – there is nowhere to hide,” said AIU chair David Howman.

Ekiru won at least 10 marathons or half-marathons between 2017 and 2021.

(Reporting by Lori Ewing; Editing by Christian Radnedge)

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

MOST VIEWED STORIES

FROM THE NICHE TITLES